New York, NY – June 11, 2024 – Tenex Capital Management (“Tenex”) is pleased to announce an investment in Behavioral Innovations (“BI” or “the Company”), a leading provider of center-based Applied Behavior Analysis therapy (“ABA”) to early intervention children with Autism Spectrum Disorder (“ASD”) and other related developmental disabilities.
Headquartered in Addison, TX, Behavioral Innovations was co-founded in 2000 by Carla Edwards and Lori Russo, both Board Certified Behavior Analysts (“BCBAs”), who continue to lead the clinical organization today. BI has since grown to 77 locations across Texas, Oklahoma, and Colorado. The Company offers individualized treatment plans and parent education services aimed at alleviating the symptoms of ASD and providing real-world improvements in patients’ lives.
Behavioral Innovations CEO, Dino Eliopoulos, commented, “We are extremely pleased to partner with Tenex as we look to capitalize on Behavioral Innovations’ compelling growth potential through continued center expansion. Tenex is an ideal partner for us given their emphasis on quality of care and patient outcomes, operational prowess, shared vision, and track record of success in executing upon accretive growth with companies in similar situations as Behavioral Innovations.”
“Since starting Behavioral Innovations in 2000, our primary focus has been providing best-in-class clinical care and autism therapy services. I am delighted that we have maintained this since expanding and adding new centers,” said Carla Edwards, Chief Clinical Officer and Co-Founder of Behavioral Innovations. “We look forward to partnering with Tenex to continue to support children with autism and their families with clinical resources and support.”
Ryan MacIntyre, a Managing Director at Tenex Capital Management remarked, “Dino and the entire Behavioral Innovations team have built a phenomenal organization centered on delivering exceptional patient outcomes, and we are excited to support BI’s continued growth and footprint expansion.” Tenex Managing Director Varun Bedi added, “Working together, we can increase access to care for this needed service and create continued opportunity for BI’s clinicians and employees, all while ensuring a best-in-class clinical experience.”
The transaction closed on June 6, 2024. TripleTree acted as the exclusive financial advisor to Tenex. Calex served as the exclusive financial advisor to the Seller.